Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.

Victoria TserpeliDimitra StergiopoulouDora LondraLydia GiannopoulouPaul BuderathIoanna BalgkouranidouNikolaos XenidisChristina T Grech Eva Obermayr Robert ZeillingerKitty PavlakisTheodoros RampiasStylianos KakolyrisSabine Kasimir-Bauer Evi S Lianidou

Published in: Cancers (2021)

promoter could serve as a potential prognostic DNA methylation biomarker and a predictor of resistance to platinum-based chemotherapy in ovarian cancer.

Keyphrases

high grade
dna methylation
low grade
genome wide
gene expression
locally advanced
copy number
risk assessment
radiation therapy
rectal cancer